Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | LMNA | P02545 | 4/20 | 0.31 |
| ▸ | MAPT | P10636 | 4/20 | 0.31 |
| ▸ | HPGD | P15428 | 4/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.31 |
| ▸ | MGLL | Q99685 | 2/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2463807 | 0.82 | ALDH1A1 (0.32) | ALDH1A1LMNAMAPTHPGDHSD17B10 | |
| SCHEMBL17883835 | 0.77 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL5482178 | 0.77 | MME (0.43) | ALDH1A1LMNAMAPTHPGDHSD17B10 | |
| SCHEMBL19646439 | 0.74 | TP53 (0.35) | ALDH1A1LMNAMAPTHPGDHSD17B10 | |
| SCHEMBL6509922 | 0.73 | PTGS1 (0.33) | ALDH1A1PTGS1PTGS2MGLLFAAH | |
| SCHEMBL7199030 | 0.72 | MME (0.45) | ALDH1A1LMNAMAPTHPGDHTT | |
| SCHEMBL4536010 | 0.72 | MME (0.39) | ALDH1A1LMNAMAPTHSD17B10PTGS1 | |
| SCHEMBL23801584 | 0.71 | TP53 (0.33) | ALDH1A1LMNAMAPTHPGDHSD17B10 | |
| SCHEMBL26806814 | 0.71 | TP53 (0.33) | ALDH1A1LMNAMAPTHPGDHSD17B10 | |
| SCHEMBL21575560 | 0.71 | MME (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150231635-A1 | CELLOMICS SYSTEM | ON-CHIP CELLOMICS CONSORTIUM (JP) | 2015-08-20 | — | — | US | disclosed |
| US-20130252848-A1 | CELLOMICS SYSTEM | KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY (JP) | 2013-09-26 | — | — | US | disclosed |
| US-20100018862-A1 | CELLOMICS SYSTEM | OKANO KAZUNORI | 2010-01-28 | — | — | US | disclosed |
| US-20100021933-A1 | CELLOMICS SYSTEMS | OKANO KAZUNORI | 2010-01-28 | — | — | US | disclosed |
| US-20100016568-A1 | CELLOMICS SYSTEM | KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY (JP) | 2010-01-21 | — | — | US | disclosed |
| US-20100016569-A1 | CELLOMICS SYSTEM | OKANO KAZUNORI | 2010-01-21 | — | — | US | disclosed |
| US-20090325215-A1 | CELLOMICS SYSTEM | OKANO KAZUNORI | 2009-12-31 | — | — | US | disclosed |
| US-7569354-B2 | Cellomics system | ONCHIP CELLOMICS CONSORTIUM (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20090042200-A1 | CELLOMICS SYSTEM | OKANO KAZUNORI | 2009-02-12 | — | — | US | disclosed |
| US-20090042739-A1 | CELLOMICS SYSTEM | OKANO KAZUNORI | 2009-02-12 | — | — | US | disclosed |
| EP-1901067-A2 | Cellomics system | On-Chip Biotechnologies Co., Ltd. (JP) | 2008-03-19 | — | — | EP | disclosed |
| US-20070059763-A1 | Cellomics system | ON CHIP CELLOMICS CONSORTIUM (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1626278-A2 | Cellomics system | OnChip Cellomics Consortium (JP) | 2006-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150231635-A1 | CELLOMICS SYSTEM | SLC3A2, STUB1, EPCAM | ALDH1A1 742/4885LMNA 2792/4885MAPT 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.